Hemostatics

Barcelona, Spain

Hemostatics is developing a novel antifibrinolytic agent to reduce bleeding in life-threatening and disabling hemorrhagic conditions.

$1.1M raised

Jan 2024

Grant

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Hemostatics

How much funding has Hemostatics raised?

Hemostatics has raised $1.1M in total funding. The most recent round was Grant. The last funding was announced in January 2024.

Where is Hemostatics headquartered?

Hemostatics is headquartered in Barcelona, Spain.

What does Hemostatics do?

Hemostatics is developing a novel antifibrinolytic agent to reduce bleeding in life-threatening and disabling hemorrhagic conditions.

What stage is Hemostatics at?

Hemostatics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 1, 2024.

MLA

"Hemostatics — Funding & Investors." VCBacked, January 1, 2024, https://www.vcbacked.co/company/hemostatics. Accessed July 3, 2026.

APA

VCBacked. (2024). Hemostatics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/hemostatics

Wikipedia (cite web)

{{cite web |title=Hemostatics — Funding & Investors |url=https://www.vcbacked.co/company/hemostatics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 1, 2024.